Individual health discount rate in patients with ulcerative colitis

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1328-1332

  Waljee, Akbar K ^a   Morris, Arden M ^b   Waljee, Jennifer F ^b   Higgins, Peter D R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

discount rates; quality of life; ulcerative colitis; utilities

Indexed keywords

ADULT; AGED; ARTICLE; COLON RESECTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLITIS, ULCERATIVE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DECISION MAKING; FEMALE; HEALTH STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT PREFERENCE; RISK ASSESSMENT; YOUNG ADULT;

EID: 79955866215     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21515     Document Type: Article

References (26)

1. Carter MJ, Lobo AJ, Travis SP., Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004; 53 (suppl 5): V1-16. (Pubitemid 39120096)
2. Ingle SB, Dhillon S, Harmsen WS, et al. Risk factors associated with hospitalization among ulcerative colitis patients from Olmsted County, Minnesota, 1970-2001. (Abstract) UEGW. Paris; 2007.
3. Siegel CA, Levy LC, Mackenzie TA, et al. Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14: 1-6. (Pubitemid 351196861)
4. Man-Son-Hing M, Laupacis A, O'Connor AM, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA. 1999; 282: 737-743. (Pubitemid 29404379)
5. Olsen JA., On what basis should health be discounted? J Health Econ. 1993; 12: 39-53. (Pubitemid 23183894)
6. Krahn M, Gafni A., Discounting in the economic evaluation of health care interventions. Med Care. 1993; 31: 403-418.
7. Gold MR., Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
8. Smith DH, Gravelle H., The practice of discounting in economic evaluations of healthcare interventions. Int J Technol Assess Health Care. 2001; 17: 236-243. (Pubitemid 32574961)
9. Arias E., United States life tables. National Vital Statistics Report; 2006:54.
10. Wikipedia. Compound interest. Available at: Accessed 23 July, 2010.
11. Austin PC., Bayesian extensions of the Tobit model for analyzing measures of health status. Med Decis Making. 2002; 22: 152-162. (Pubitemid 34246129)
12. Austin PC, Escobar M, Kopec JA., The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000; 9: 901-910. (Pubitemid 32210184)
13. Austin PC., A comparison of methods for analyzing health-related quality-of-life measures. Value Health. 2002; 5: 329-337. (Pubitemid 36998745)
14. Weinstein MC, Stason WB., Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977; 296: 716-721. (Pubitemid 8066534)
15. Loewenstein G, Prelec D., Anomalies in intertemporal choice: evidence and interpretation. Q J Econ. 1992; 107: 573-597.
16. Fishburn PC, Rubenstein A., Time preferences. Int Econ Rev. 1982; 23: 677-694.
17. Chapman GB, Nelson R, Heir D., Familiarity and time preferences: decision making about treatments for migraine headaches and Crohn's disease. J Exp Psychol. 1999; 5: 17.
18. Provenzale D, Wong JB, Onken JE, et al. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol. 1998; 93: 872-880. (Pubitemid 29076969)
19. Waljee A, Waljee J, Morris AM, et al. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006; 55: 1575-1580. (Pubitemid 44629206)
20. Ortendahl M, Fries JF., Discounting and risk characteristics in clinical decision-making. Med Sci Monit. 2006; 12: RA41-45. (Pubitemid 43332267)
21. Edwards A, Elywn G., Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care. 2001; 10: 9-13.
22. Cropper ML, Aydede SK, Portney PR., Rates of time preference for saving lives. Am Econ Rev. 1992; 82: 469-472.
23. Olsen JA., Time preferences for health gains: an empirical investigation. Health Econ. 1993; 2: 257-265.
24. Cairns JA., Valuing future benefits. Health Econ. 1994; 3: 221-229.
25. Gyrd-Hansen D, Kristiansen IS, Nexoe J, et al. How do individuals apply risk information when choosing among health care interventions ? Risk Anal. 2003; 23: 697-704. (Pubitemid 36929565)
26. Hembroff LA, Holmes-Rovner M, Willis CE., Treatment decision-making and the form of risk communication: results of a factorial study. BMC Med Inform Decis Mak. 2004; 16: 24.